A carregar...

AXL Mediates TRAIL Resistance in Esophageal Adenocarcinoma

The overexpression of AXL receptor tyrosine kinase is a frequent finding that has been associated with poor prognosis in esophageal adenocarcinoma (EAC). As the majority of EAC are intrinsically resistant to DNA-damaging therapies, an alternative therapeutic approach based on the activation of death...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hong, Jun, Belkhiri, Abbes
Formato: Artigo
Idioma:Inglês
Publicado em: Neoplasia Press Inc. 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3593152/
https://ncbi.nlm.nih.gov/pubmed/23479507
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!